Clinical results, adverse events, and change in end-organ function in elderly patients with heartmateii left ventricular assist device

Japanese multicenter study

behalf of the Japanese HeartMateII Investigators

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

Background: Advanced age has an adverse impact on clinical results in left ventricular assist device (LVAD) patients. We compared the clinical results of patients aged >60 years with younger patients using a national Japanese database. Methods and Results: Between April 2013 and December 2016, 300 patients underwent HeartMateII implantation. Of these, 37 patients were ≥60 years at LVAD implantation, and the clinical results of these patients were compared with the other younger 263 patients. At 1 and 3 years the on-device survival was 95%, 91% in younger patients, and 85%, 75% in older patients, respectively (P=0.016), although age was not a risk factor on the multivariate analysis. There was no significant difference between the groups in incidence of various adverse events except stroke. In the propensity-matching cohort, the incidence of stroke was significantly higher in patients aged >60 years (P=0.047). In patients aged >60 years, improvement of renal function was transient and there was no improvement later than 3 months, and recovery of serum albumin level to preoperative value was delayed. Conclusions: There were significant differences in the stroke incidence and recovery of end-organ functions after LVAD implantation. This may have important implications for patient selection in future destination therapy in Japan, where quality of life is an important issue in LVAD support.

元の言語英語
ページ(範囲)409-418
ページ数10
ジャーナルCirculation Journal
82
発行部数2
DOI
出版物ステータス出版済み - 1 1 2018

Fingerprint

Heart-Assist Devices
Multicenter Studies
Stroke
Incidence
Serum Albumin
Patient Selection
Japan
Multivariate Analysis
Quality of Life
Databases

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

Clinical results, adverse events, and change in end-organ function in elderly patients with heartmateii left ventricular assist device : Japanese multicenter study. / behalf of the Japanese HeartMateII Investigators.

:: Circulation Journal, 巻 82, 番号 2, 01.01.2018, p. 409-418.

研究成果: ジャーナルへの寄稿記事

@article{bda12db0f24747459ff22783f5ca0911,
title = "Clinical results, adverse events, and change in end-organ function in elderly patients with heartmateii left ventricular assist device: Japanese multicenter study",
abstract = "Background: Advanced age has an adverse impact on clinical results in left ventricular assist device (LVAD) patients. We compared the clinical results of patients aged >60 years with younger patients using a national Japanese database. Methods and Results: Between April 2013 and December 2016, 300 patients underwent HeartMateII implantation. Of these, 37 patients were ≥60 years at LVAD implantation, and the clinical results of these patients were compared with the other younger 263 patients. At 1 and 3 years the on-device survival was 95{\%}, 91{\%} in younger patients, and 85{\%}, 75{\%} in older patients, respectively (P=0.016), although age was not a risk factor on the multivariate analysis. There was no significant difference between the groups in incidence of various adverse events except stroke. In the propensity-matching cohort, the incidence of stroke was significantly higher in patients aged >60 years (P=0.047). In patients aged >60 years, improvement of renal function was transient and there was no improvement later than 3 months, and recovery of serum albumin level to preoperative value was delayed. Conclusions: There were significant differences in the stroke incidence and recovery of end-organ functions after LVAD implantation. This may have important implications for patient selection in future destination therapy in Japan, where quality of life is an important issue in LVAD support.",
author = "{behalf of the Japanese HeartMateII Investigators} and Daisuke Yoshioka and Koichi Toda and Minoru Ono and Takeshi Nakatani and Akira Shiose and Yoshiro Matsui and Kenji Yamazaki and Yoshikatsu Saiki and Akihiko Usui and Hiroshi Niinami and Goro Matsumiya and Hirokuni Arai and Yoshiki Sawa",
year = "2018",
month = "1",
day = "1",
doi = "10.1253/circj.CJ-17-0881",
language = "English",
volume = "82",
pages = "409--418",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "2",

}

TY - JOUR

T1 - Clinical results, adverse events, and change in end-organ function in elderly patients with heartmateii left ventricular assist device

T2 - Japanese multicenter study

AU - behalf of the Japanese HeartMateII Investigators

AU - Yoshioka, Daisuke

AU - Toda, Koichi

AU - Ono, Minoru

AU - Nakatani, Takeshi

AU - Shiose, Akira

AU - Matsui, Yoshiro

AU - Yamazaki, Kenji

AU - Saiki, Yoshikatsu

AU - Usui, Akihiko

AU - Niinami, Hiroshi

AU - Matsumiya, Goro

AU - Arai, Hirokuni

AU - Sawa, Yoshiki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Advanced age has an adverse impact on clinical results in left ventricular assist device (LVAD) patients. We compared the clinical results of patients aged >60 years with younger patients using a national Japanese database. Methods and Results: Between April 2013 and December 2016, 300 patients underwent HeartMateII implantation. Of these, 37 patients were ≥60 years at LVAD implantation, and the clinical results of these patients were compared with the other younger 263 patients. At 1 and 3 years the on-device survival was 95%, 91% in younger patients, and 85%, 75% in older patients, respectively (P=0.016), although age was not a risk factor on the multivariate analysis. There was no significant difference between the groups in incidence of various adverse events except stroke. In the propensity-matching cohort, the incidence of stroke was significantly higher in patients aged >60 years (P=0.047). In patients aged >60 years, improvement of renal function was transient and there was no improvement later than 3 months, and recovery of serum albumin level to preoperative value was delayed. Conclusions: There were significant differences in the stroke incidence and recovery of end-organ functions after LVAD implantation. This may have important implications for patient selection in future destination therapy in Japan, where quality of life is an important issue in LVAD support.

AB - Background: Advanced age has an adverse impact on clinical results in left ventricular assist device (LVAD) patients. We compared the clinical results of patients aged >60 years with younger patients using a national Japanese database. Methods and Results: Between April 2013 and December 2016, 300 patients underwent HeartMateII implantation. Of these, 37 patients were ≥60 years at LVAD implantation, and the clinical results of these patients were compared with the other younger 263 patients. At 1 and 3 years the on-device survival was 95%, 91% in younger patients, and 85%, 75% in older patients, respectively (P=0.016), although age was not a risk factor on the multivariate analysis. There was no significant difference between the groups in incidence of various adverse events except stroke. In the propensity-matching cohort, the incidence of stroke was significantly higher in patients aged >60 years (P=0.047). In patients aged >60 years, improvement of renal function was transient and there was no improvement later than 3 months, and recovery of serum albumin level to preoperative value was delayed. Conclusions: There were significant differences in the stroke incidence and recovery of end-organ functions after LVAD implantation. This may have important implications for patient selection in future destination therapy in Japan, where quality of life is an important issue in LVAD support.

UR - http://www.scopus.com/inward/record.url?scp=85041021134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041021134&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-17-0881

DO - 10.1253/circj.CJ-17-0881

M3 - Article

VL - 82

SP - 409

EP - 418

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 2

ER -